Science & Enterprise subscription

Follow us on Twitter

  • Wearers of Fitbit activity tracking devices now have the option of sharing their data with a large-scale precision… https://t.co/2tKDCzwGDq
    about 3 hours ago
  • New post on Science and Enterprise: Fitbit Devices Providing Precision Medicine Data https://t.co/6BoD4wI5lI #Science #Business
    about 4 hours ago
  • An alliance of research organizations is designing ways to cut the time needed to develop, test, and manufacture ne… https://t.co/8mnuBqb6q0
    about 7 hours ago
  • New post on Science and Enterprise: Consortium to Speed Vaccine Production https://t.co/uU6E9yjKR9 #Science #Business
    about 7 hours ago
  • New contributed post on Science and Enterprise: https://t.co/iwQvJe2XGc How Your Company Can Make a Positive Impact on the World
    about 10 hours ago

Please share Science & Enterprise

RSS
Follow by Email
Facebook
Facebook
Google+
Twitter
Visit Us
LinkedIn
INSTAGRAM

Genome Editing, Informatics Lead to New Antibiotic

Antibiotics from engineered bacteria

Researchers in the U.K. created an antibiotic acid from a natural microbe found in soil, using a combination of the genome editing technique Crispr and bioinformatics. . . . → Read More: Genome Editing, Informatics Lead to New Antibiotic

Model Biotech Materials Sharing Agreement Unveiled

Lab jars and beakers

A document with standard legal language for terms and conditions of sharing biotechnology materials is now available for academic and industry research labs. . . . → Read More: Model Biotech Materials Sharing Agreement Unveiled

Artificial Pancreas Controls Type 1 Diabetes Better Than Insulin Pump Alone

Diabetes word cloud

A clinical trial shows a closed-loop algorithm-controlled artificial pancreas system helps people with type 1 diabetes better control their blood sugar levels than a glucose sensor and insulin pump system alone. . . . → Read More: Artificial Pancreas Controls Type 1 Diabetes Better Than Insulin Pump Alone

Jet Fuel from Carbon Waste Powers Virgin Atlantic flight

Richard Branson at Gatwick

A Virgin Atlantic flight arriving earlier today from Orlando, Florida to London’s Gatwick airport is the first to use a biofuel made from fermented carbon-rich industrial waste gases. . . . → Read More: Jet Fuel from Carbon Waste Powers Virgin Atlantic flight

Human Antibodies Devised for Snakebite Treatment

Black mamba snake

An academic-industry team in Europe and Central America assembled a group of human antibodies that protects lab mice against venomous toxins from a dangerous African snake. . . . → Read More: Human Antibodies Devised for Snakebite Treatment

Spin-Off Company Developing New Antibiotics

MRSA bacteria

A start-up enterprise in the U.K. is commercializing research from a university lab that discovered a new class of antibiotics promising to treat drug-resistant bacterial infections. . . . → Read More: Spin-Off Company Developing New Antibiotics

Virtual Reality Therapy Company Gains $5.1M in Early Funds

Scene from VR program

A company in the U.K. developing automated treatments for phobias using immersive virtual reality is raising £3.2 million ($US 5.1 million) in its first venture funding round. . . . → Read More: Virtual Reality Therapy Company Gains $5.1M in Early Funds

Univ. Spin-Off Developing A.I.-Boosted Heart Monitor

Heartbeat graphic

A new enterprise in the U.K. is developing a wearable heart monitor that diagnoses irregular heart rhythms with artificial intelligence using cloud-based algorithms. . . . → Read More: Univ. Spin-Off Developing A.I.-Boosted Heart Monitor

Scientists, Investors Form $100M+ Tech Venture Fund

Pen and calculator

A group of entrepreneurs and leading scientists in the U.K. unveiled a venture investment fund that plans to back start-up companies developing a wide range of ground-breaking technologies. . . . → Read More: Scientists, Investors Form $100M+ Tech Venture Fund

Drug Discovery System Designed to Identify Difficult Targets

Nerve cells in brain

A lab in the U.K. developed a system for discovering new therapies that identify therapy targets linked to enzymes, some found in neurodegenerative diseases, previously considered too difficult to address. . . . → Read More: Drug Discovery System Designed to Identify Difficult Targets